Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment

S. W. Lewis, L. Davies, P. B. Jones, T. R E Barnes, R. M. Murray, R. Kerwin, D. Taylor, Karen Hayhurst, A. Markwick, H. Lloyd, G. Dunn

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment'. Together they form a unique fingerprint.

Nursing and Health Professions

Psychology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Medicine and Dentistry